Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD
5.18 0.19 (3.81%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap209.64M
Revenue (ttm)n/a
Net Income (ttm)-93.01M
Shares Out40.47M
EPS (ttm)-9.31
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume201,896
Open5.20
Previous Close4.99
Day's Range4.97 - 5.39
52-Week Range4.95 - 26.98
Betan/a
AnalystsBuy
Price Target24.00 (+363.3%)
Earnings DateNov 15, 2021

About ABOS

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.

IndustryBiotechnology
IPO DateJul 1, 2021
Employees7
Stock ExchangeNASDAQ
Ticker SymbolABOS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for ABOS stock is "Buy." The 12-month stock price forecast is 24.00, which is an increase of 363.32% from the latest price.

Price Target
$24.00
(363.32% upside)
Analyst Consensus: Buy

News

Acumen Pharmaceuticals Reports Financial Results for Third Quarter 2021 and Business Highlights

CHARLOTTESVILLE, Va. and CARMEL, Ind., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical company focused on the development of novel targe...

2 months ago - GlobeNewsWire

Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2021 and Business Highlights

CHARLOTTESVILLE, Va. and CARMEL, Ind., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen), a clinical stage biopharmaceutical company focused on the development of no...

5 months ago - GlobeNewsWire

5 Stocks With High Insider Cluster Buys During July

According to the Insider Cluster Buys Screen, a Premium feature of Gurus, five stocks with high number of unique insider buys during the past month include German American Bancorp Inc. ( GABC , Financia...

Other symbols:ATLOGABCPTRSSPG
5 months ago - GuruFocus

Acumen Pharmaceuticals shares soar 25% in trading debut

Acumen Pharmaceuticals Inc. shares soared 25% in their trading debut Thursday, after the biotech's initial public offering priced at the high end of its proposed range. Acumen sold 10 million shares at ...

6 months ago - Market Watch

Acumen Pharmaceuticals Announces Pricing of Upsized Initial Public Offering

CHARLOTTESVILLE, Va., June 30, 2021 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (“Acumen” or “Acumen Pharmaceuticals”) (Nasdaq: ABOS), a clinical-stage biopharmaceutical company developing a novel ...

6 months ago - GlobeNewsWire